Company Profile

Nanospectra Biosciences Inc (AKA: Nanospectra )
Profile last edited on: 6/15/2021      CAGE: 3D4C0      UEI: CQEPCKVGYKX4

Business Identifier: Particle-based therapies for the selective and precise thermal destruction of solid tumors
Year Founded
2001
First Award
2001
Latest Award
2010
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8285 El Rio Street Suite 150
Houston, TX 77054
   (713) 842-2720
   N/A
   www.nanospectra.com
Location: Single
Congr. District: 09
County: Harris

Public Profile

Nanospectra Biosciences is a medical device company pioneering a novel use of nanomedicine for selective thermal ablation. Anchored in intellectual property licensed from Rice University and collaborative research with scientists at MD Anderson Cancer Center, Nanospectra is commercializing a particle-based therapy for the precise thermal destruction of solid tumors. By allowing the systemically delivered particles to determine the zones of ablation -- rather than the placement of an energy source-- AuroLase™ Therapy can thermally ablate irregularly shaped tumors or inoperable tumors while minimizing damage to healthy adjacent tissue and preserving nearby critical structures.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  David Jorden -- Interim CEO and Director

  Michael Brawer -- Chief Medical Officer

  Chris L Coleman

  Glenn Goodrich -- Vice President, COO Process Development and Chemistry

  Naomi Halas -- Co-Founder

  Joseph B Jackson

  Patrick D O'Neal

  J Donald Payne -- former President

  Jainxia Qiu

  Jon Schwartz

  Jon Alexander Schwartz -- Director, Clinical Research

  Dan Watkins -- Co-Founder and Dircetor

  Jennifer West -- Co-Founder & Board of Directors

Company News

There are no news available.